tradingkey.logo

Inogen Inc

INGN
查看詳細走勢圖
6.750USD
+0.040+0.60%
收盤 12/22, 16:00美東報價延遲15分鐘
183.25M總市值
虧損本益比TTM

Inogen Inc

6.750
+0.040+0.60%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.60%

5天

-4.39%

1月

-1.89%

6月

+1.66%

今年開始到現在

-26.39%

1年

-20.40%

查看詳細走勢圖

TradingKey Inogen Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Inogen Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名73/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價13.00。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Inogen Inc評分

相關信息

行業排名
73 / 208
全市場排名
174 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 2 分析師
買入
評級
13.000
目標均價
+94.90%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Inogen Inc亮點

亮點風險
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
估值低估
公司最新PE估值-6.70,處於3年歷史低位
機構減倉
最新機構持股19.98M股,環比減少18.67%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉19.88K股

Inogen Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Inogen Inc簡介

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
公司代碼INGN
公司Inogen Inc
CEOSmith (Kevin R. M)
網址https://www.inogen.com/

常見問題

Inogen Inc(INGN)的當前股價是多少?

Inogen Inc(INGN)的當前股價是 6.750。

Inogen Inc 的股票代碼是什麼?

Inogen Inc的股票代碼是INGN。

Inogen Inc股票的52週最高點是多少?

Inogen Inc股票的52週最高點是12.910。

Inogen Inc股票的52週最低點是多少?

Inogen Inc股票的52週最低點是5.700。

Inogen Inc的市值是多少?

Inogen Inc的市值是183.25M。

Inogen Inc的淨利潤是多少?

Inogen Inc的淨利潤為-35.89M。

現在Inogen Inc(INGN)的股票是買入、持有還是賣出?

根據分析師評級,Inogen Inc(INGN)的總體評級為買入,目標價格為13.000。

Inogen Inc(INGN)股票的每股收益(EPS TTM)是多少

Inogen Inc(INGN)股票的每股收益(EPS TTM)是-1.001。
KeyAI